BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 15271195)

  • 1. Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage.
    Abeck D;
    Int J Dermatol; 2004 Jul; 43 Suppl 1():13-6. PubMed ID: 15271195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial.
    Altmeyer P; Hoffmann K;
    Int J Dermatol; 2004 Jul; 43 Suppl 1():9-12. PubMed ID: 15271194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial.
    Lebwohl M; Plott T
    Int J Dermatol; 2004 Jul; 43 Suppl 1():17-20. PubMed ID: 15271196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.
    Shuster S; Meynadier J; Kerl H; Nolting S
    Arch Dermatol; 2005 Jan; 141(1):47-52. PubMed ID: 15655141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis.
    Ratnavel RC; Squire RA; Boorman GC
    J Dermatolog Treat; 2007; 18(2):88-96. PubMed ID: 17520465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis.
    Gupta AK; Nicol KA
    Int J Dermatol; 2006 Jan; 45(1):66-9. PubMed ID: 16426382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis.
    Squire RA; Goode K
    J Dermatolog Treat; 2002 Jun; 13(2):51-60. PubMed ID: 12060502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciclopirox shampoo for treating seborrheic dermatitis.
    Gupta AK; Bluhm R
    Skin Therapy Lett; 2004; 9(6):4-5. PubMed ID: 15334279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciclopirox gel for seborrheic dermatitis of the scalp.
    Aly R; Katz HI; Kempers SE; Lookingbill DP; Lowe N; Menter A; Morman M; Savin RC; Wortzman M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():19-22. PubMed ID: 12895183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of 1% ciclopirox shampoo in the treatment of moderate-to-severe scalp seborrheic dermatitis: a multicenter, prospective, assessor-blinded trial.
    Veraldi S; Barbareschi M; Martella A; Milani M
    G Ital Dermatol Venereol; 2019 Jun; 154(3):342-346. PubMed ID: 31001967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment.
    Lorette G; Ermosilla V
    Eur J Dermatol; 2006; 16(5):558-64. PubMed ID: 17101479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis.
    Seite S; Rougier A; Talarico S
    J Cosmet Dermatol; 2009 Dec; 8(4):249-53. PubMed ID: 19958427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial.
    Gupta AK; Skinner AR; Cooper EA
    Int J Dermatol; 2005 Jul; 44(7):590-3. PubMed ID: 15985032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison.
    Unholzer A; Varigos G; Nicholls D; Schinzel S; Nietsch KH; Ulbricht H; Korting HC
    Infection; 2002 Dec; 30(6):373-6. PubMed ID: 12478328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study.
    Reygagne P; Poncet M; Sidou F; Soto P
    Cutis; 2007 May; 79(5):397-403. PubMed ID: 17569404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea.
    Lee JH; Lee HS; Eun HC; Cho KH
    J Dermatolog Treat; 2003 Dec; 14(4):212-5. PubMed ID: 14660265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lipohydroxyacid-containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light-to-moderate scalp psoriasis.
    Seité S; Paries J; Reygagne P; Hamidou Z; Jouanique C; Perez-Pala G; Rougier A
    J Cosmet Dermatol; 2009 Jun; 8(2):108-13. PubMed ID: 19527334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter, double-blind, parallel group study investigating the non-inferiority of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2% ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp.
    Buechner SA
    J Dermatolog Treat; 2014 Jun; 25(3):226-31. PubMed ID: 23557492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis.
    Poulin Y; Papp K; Bissonnette R; Barber K; Kerrouche N; Villemagne H;
    J Dermatolog Treat; 2010 May; 21(3):185-92. PubMed ID: 20131980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.